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Abstract
Background: Alveolar macrophages play an important role during the development of acute
inflammatory lung injury. In the present study, in vivo alveolar macrophage depletion was performed
by intratracheal application of dichloromethylene diphosphonate-liposomes in order to study the
role of these effector cells in the early endotoxin-induced lung injury.
Methods:  Lipopolysaccharide was applied intratracheally and the inflammatory reaction was
assessed 4 hours later. Neutrophil accumulation and expression of inflammatory mediators were
determined. To further analyze in vivo observations, in vitro experiments with alveolar epithelial cells
and alveolar macrophages were performed.
Results: A 320% increase of polymorphonuclear leukocytes in bronchoalveolar lavage fluid was
observed in macrophage-depleted compared to macrophage-competent lipopolysaccharide-
animals. This neutrophil recruitment was also confirmed in the interstitial space. Monocyte
chemoattractant protein-1 concentration in bronchoalveolar lavage fluid was significantly increased
in the absence of alveolar macrophages. This phenomenon was underlined by in vitro experiments
with alveolar epithelial cells and alveolar macrophages. Neutralizing monocyte chemoattractant
protein-1 in the airways diminished neutrophil accumulation.
Conclusion:  These data suggest that alveolar macorphages play an important role in early
endotoxin-induced lung injury. They prevent neutrophil influx by controlling monocyte
chemoattractant protein-1 production through alveolar epithelial cells. Alveolar macrophages
might therefore possess robust anti-inflammatory effects.
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Introduction
Lipopolysaccharide (LPS) is a component of the outer
membrane of gram-negative bacteria, capable of inducing
severe lung injury in sepsis or bacterial pneumonia upon
release. Both conditions are predisposing causes of the
acute respiratory distress syndrome (ARDS). Instillation
of LPS into the lungs results in an acute inflammatory
response orchestrated by the coordinated function of
cytokines, chemokines, and adhesion molecules. In vitro
and in vivo models of acute lung inflammation have been
extensively used to elucidate the molecular mechanisms
in endotoxin-induced lung injury [1-3]. However, only
sparse data exist about the exact role of effector cells such
as alveolar macrophages (AM) in the respiratory compart-
ment in this type of injury.
The airway compartment with alveolar macrophages and
epithelial cells as the predominant cell types is a physio-
logical barrier to a variety of environmental agents includ-
ing gases, particulates and microbes. An injury to lung
tissue involving the airway compartment can lead to seri-
ous illness and life-threatening conditions such as ARDS.
AM are located at the air-tissue interface in the lung and
are therefore the first cells, which interact with inhaled
organisms and antigens [4]. During the development of
an acute inflammatory lung injury, AM play a very impor-
tant role upon their activation. It has been shown in sev-
eral lung injury models that activated pulmonary
macrophages release the cytokines tumor necrosis factor-
α (TNF-α) and interleukin-1β (IL-1β) as well as the chem-
okines monocyte chemoattractant protein-1 (MCP-1) and
macrophage inflammatory protein-1β (MIP-1β) [5].
Intercellular adhesion molecule-1 (ICAM-1, CD54) and
vascular cell adhesion molecule-1 (VCAM-1, CD106) are
adhesion molecules of the immunoglobulin superfamily.
Adhesion to vascular endothelium mediated through
ICAM-1/VCAM-1-integrin interactions is a key step in
emigration of white blood cells to sites of inflammation
[6]. It has also been shown that they play a central role in
adherence of effectors cells such as AM to the respiratory
epithelium [7]. All these inflammatory mediators together
play a crucial role in the orchestration of an inflammatory
response, particularly in neutrophil recruitment. Recent
studies suggest that cytokines and chemokines do not
only originate from AM, but also from other cells such as
epithelial cells [8].
In order to study the role and function of AM regarding
inflammatory mediators in endotoxin-induced lung
injury, AM were depleted by intratracheal application of
dichloromethylene diphosphonate-(Cl2MDP)-liposomes
(clodronate liposomes) as phagolysozymes. Phagocytosis
of clodronate-liposomes has been shown to result in the
selective destruction of macrophages with an elimination
rate up to 80% [9]. Cellular and molecular immun-
opathologic characteristics in endotoxin-induced lung
injury of non-depleted and AM-depleted animals were
investigated, focusing on neutrophil recruitment and
expression of inflammatory mediators. The hypothesis
was tested if AM upon LPS stimulation have an anti-or
proinflammatory character.
Materials and methods
Animals
Male pathogen-free 300 g Wistar rats (RCC Ltd, Fül-
linsdorf, Switzerland) were anesthetized with subcutane-
ous fentanyl-fluanisone (0.25 ml/kg) and medetomidine
hydrochloridum (0.25 ml/kg). The animal care commit-
tees at the University of Zurich approved the experimental
protocols.
Clodronate Liposomes
Clodronate liposomes were prepared as described [10]. To
verify any possible contamination with LPS, endotoxin
levels were measured using an in vitro analysis of endo-
toxin (Limulus-Test; Endotell, Allschwil, Switzerland).
With the negative results of these tests any biologically rel-
evant contamination with LPS could be ruled out. Clodr-
onate is a synthetic bisphosphonate which has been used
to selectively eliminate macrophages in various tissues.
Uptake of liposomal-encapsulated clodronate has been
demonstrated by macrophages and monocytes, undergo-
ing apoptosis in response to clodronate. Each animal
received a dose of 500 µg liposome-encapsulated clodro-
nate. Empty liposomes were used as controls. Liposomes
were diluted in 300 µl phosphate-buffered saline (PBS)
and instilled into the trachea of the animals.
LPS Lung Injury
72 hours after liposome application animals were anes-
thetized again and lung injury was induced by intratra-
cheal application of 150 µg LPS (Escherichia coli serotype
055:B5; Sigma Chemical Co, St. Louis, MO) in 300 µl PBS.
Animals were sacrificed 4 hours or 24 hours later and
lungs were analyzed.
For inhibition experiments rats received 100 µg intratra-
cheally applied polyclonal neutralizing rabbit anti-rat
MCP-1 antibodies or control IgG (both from Torrey Pines
Biolabs, Houston, TX) 30 minutes after intratracheal
instillation of LPS or PBS.
Bronchoalveolar Lavage Fluid (BALF)
Bronchoalveolar lavage was performed with 10 ml cold
PBS. BALF was centrifuged and the supernatant aliquoted
and stored at -20°C. Cells were counted and differentiated
using a cytospin and Diff-Quick staining (Dade Behring
AG, Düdingen).Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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Myeloperoxidase (MPO) Assay
In order to determine the parenchymal content of neu-
trophils, a MPO assay was performed as previously
described [11]. The vascular and respiratory compartment
were flushed with PBS in order to eliminate blood cells,
notably neutrophils.
ELISA Quantitation of TNF-α, MCP-1, and Chemokine-
Inducible Neutrophil Chemoattractant-1 (CINC-1) in 
BALF
TNF-α, MCP-1, and CINC-1 were assessed in the BALF of
animals using a standard enzyme-linked immunosorbent
assay (ELISA) purchased from PharMingen, San Diego,
CA (TNF-α and MCP-1) and from R&D Systems, Minne-
apolis, MN (CINC-1 Duoset).
Western Blot Analysis of TNF-α, MCP-1, MIP-1β, and 
Macrophage Inflammatory Protein-2 (MIP-2) in BALF
BALF of animals were loaded and electrophoresed in a
7.5% SDS-polyacrylamide gel. After separation, the pro-
teins were transblotted to a nitrocellulose membrane.
Incubation with a polyclonal goat anti-rat TNF-α, anti-rat
MCP-1, and anti-MIP-2 antibody (all from Santa Cruz
Biotechnology, Santa Cruz, CA) or with a polyclonal rab-
bit anti-rat MIP-1β (Santa Cruz Biotechnology, Santa
Cruz, CA) was performed overnight at 4°C. A secondary
horseradish peroxidase-labeled anti-goat or anti-rabbit
IgG (1:5000) was added for 30 minutes at room tempera-
ture. Signals were detected by enhanced
chemiluminescence.
Isolation and Reverse Transcription PCR Amplification of 
Lung mRNA
The vascular and respiratory compartments were flushed
before using the lungs for determination of mRNA of var-
ious genes. Total RNA from lungs was extracted as previ-
ously described and analyzed by Reverse Transcription
Polymerase Chain Reaction (RT-PCR) (Perkin-Elmer,
Branchburg, NJ) [7]. The primers used for gene analysis
are summarized in Tab. 1. PCR was also performed with
18S primers to ensure equal loading and mRNA/18S
ratios were calculated.
In vitro Assay with Alveolar Epithelial Cells (AEC)
AEC from rat lungs were collected following previously
described protocols [12]. Cell purity of AEC was more
than 95%. AM were harvested following an earlier proto-
col [7]. AEC were kept for 5 days in culture. Most of the
cells showed type I phenotype. At the time of co-culture
with AM, AEC were confluent. To each well of a 96-well
plate with AEC 1 × 107 AM were added. The relation of AM
to AEC was 1:2 (1 × 107 and 2 × 107), when the experi-
ments were performed, according to previous studies [13].
AM were allowed to settle on AEC for 30 min prior to the
addition of LPS. As a control AEC and AM were stimulated
separately. Supernatants were collected and ELISA (TNF-
α, MCP-1) or Western blot (MIP-1β) was performed as
described above.
Chemotaxis Assays
1 × 105 polymorphonuclear cells (PMN) of calcein-AM
labelled neutrophils were given into MultiScreen-MIC fil-
ter plates [14]. Receiver plates were loaded with 150 µl of
BALF. To some of these wells, 10 µg/ml polyclonal
Table 1: Optimized conditions for RT-PCR
Size of PCR
Gene Primers Fragments (bp) Thermocycle Condition
TNF-α sense 5'-ACT GAA CTT CGG GGT GAT TG-3' 334 23 cycles; Tm: 57°C
antisense 5'-GTG GGT GAG GAG CAG GTA GT-3'
IL-1β sense 5'-AGC TGC ACT GCA GGC TTC GAG ATG-3' 339 28 cycles; Tm: 68°C
antisense 5'-GAA CTG TGC AGA CTC AAA CTC CAC-3'
MCP-1 sense 5'-TAT GCA GGT CTC TGT CAC GC-3' 255 24 cycles; Tm: 58°C
antisense 5'-TTC CTT ATT GGG GTC AGC AC-3'
MIP-1β sense 5'-CGT GTC TGC CTT CTC TCT CC-3' 220 24 cycles; Tm: 58°C
antisense 5'-CAC AGA TTT GCC TGC CTT TT-3'
ICAM-1 sense 5'-AGG TAT CCA TCC ATC CCA CA-3' 660 22 cycles; Tm: 58°C
antisense 5'-CTT CAG AGG CAG GAA ACA GG-3'
VCAM-1 sense 5'-CGG TCA TGG TCA AGT GTT TG-3' 570 24 cycles; Tm: 57°C
antisense 5'-ACC CTC ATG TAG CCT TGT GG-3'Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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neutralizing rabbit anti-rat MCP-1 (Torrey Pines Biolabs,
Houston, TX) or 10 µg/ml control IgG (Torrey Pines
Biolabs, Houston, TX) were added. For experiments with
CINC-1 antibodies 10 µg/ml monoclonal mouse anti-rat
CINC-1 antibody (R&D Systems, Europe Ltd., Abingdon,
Oxon, UK) or 10 µg/ml MOPC-21 as control (mouse IgG,
Pharmingen, San Diego, CA) were used. 0.1 µM of the
chemotactic substance fMLP (Sigma-Aldrich, Buchs, Swit-
zerland) was taken as positive control and PBS/1% fetal
bovine serum (FBS) to determine basal migration. After 2
hours incubation at 37°C the filter was removed and
migrated cells were lysed with Triton 1% (Sigma-Aldrich,
Buchs, Switzerland). Fluorescence was measured by using
an excitation filter at 485 nm and an emission filter at 535
nm. Ratio between stimulated and basal migration was
used as indication of PMN chemotaxis.
Statistical Methods
For each group and/or time point 5 animals were used.
The relative reduction in mRNA or protein expression was
calculated for LPS clodronate-liposome results. LPS con-
trol liposome and LPS clodronate-liposome values were
calculated relative to their respective PBS liposome values.
LPS clodronate-liposome reduction or upregulation was
calculated as the relative change compared to LPS control
liposome results. ELISA contained three replicates with
five different animals. Each data point in the graphs rep-
resents mean +/- standard error of mean (SEM). Analysis
of variance (ANOVA) with post-ANOVA comparison was
performed to assess the statistical significance of
differences.
Results
Macrophage Depletion
Before experiments with clodronate-liposomes were
started, different depletion conditions were evaluated as
described [15]. Optimal depletion was seen at a dose of
500 µg for 72 hours. Depletion was verified with macro-
phage staining in BALF showing a depletion of 75–80%,
which was consistent with previous reports [16]. Normal
rats, not treated with liposomes, had 1.6 × 106 cells (all
macrophages) in BALF. 72 hours after liposome instilla-
tion, cell count in BALF of control liposome animals
showed 2.2 × 106 cells (all macrophages), while cells of
BALF of clodronate-liposome pretreated animals had 1.0
× 106 cells (0.5 × 106 macrophages and 0.5 × 106 neu-
trophils). The phenomenon of a slight neutrophil recruit-
ment induced by clodronate is a known observation [17].
Detection of Cell Types in BALF and Determination of 
Interstitial PMN Recruitment
Cells from control-and clodronate-liposome animals,
receiving PBS or LPS, were analyzed in BALF (Fig. 1A).
Total cell count in BALF of control liposome animals with
intratracheal PBS was 2.5 × 106 cells (all macrophages). In
PBS-animals pretreated with clodronate-liposomes, cell
count decreased to 1.2 × 106 cells (0.6 × 106 macrophages,
0.6 × 106 neutrophils). BALF of control liposome-animals,
receiving LPS, showed 10.0 × 106 cells (4-fold increase),
while in clodronate-animals with LPS, 36.5 × 106 cells
were detected in BALF. The difference between LPS-ani-
mals with and without AM was 320% (p < 0.0001). The
absolute increase of AM from 0.6 × 106 cells in clodronate-
PBS animals compared to clodronate-LPS animals with
1.5 × 106 cells might be due to a recruitment of interstitial
macrophages.
To determine whether the amount of interstitial neu-
trophils changed between AM-competent and AM-
depleted animals, lungs were harvested 4 hours after
intratracheal application of PBS or LPS. The vascular and
airway compartment were flushed, and MPO activity was
determined (Fig. 1B). Results of AM-competent PBS-ani-
mals were defined as 1, while other results were adapted.
Intratracheal application of LPS resulted in a 115%
enhancement of MPO. A 220% increase in lung MPO
activity was observed in LPS-animals without AM as com-
pared to AM-competent animals (p < 0.005).
TNF-α, MCP-1, MIP-1β, MIP-2, and CINC-1 Protein 
Determination in BALF
The assessment of inflammatory cells showed a significant
increase of neutrophils in AM-depleted LPS-animals as
compared to non-depleted LPS-animals. Therefore, three
potentially activating and chemotactic cytokines and
chemokines in the BALF were examined: TNF-α, MCP-1
and MIP-1β.
As shown by ELISA in Tab. 2 TNF-α was not detectable in
control-and clodronate-liposome animals treated with
PBS. However, TNF-α concentration in control liposome
LPS-animals increased up to 3.4 ng/ml, while AM-
depleted LPS-animals had only 1 ng/ml TNF-α (71%
decrease, p < 0.001). Therefore, AM – rather than the
increased number of neutrophils – appear to be a major
source of TNF-α protein in BALF of LPS-injured lungs.
Contrary to TNF-α, MCP-1 protein in LPS-injured animals
increased from 8.0 ng/ml to 21.5 ng/ml upon AM deple-
tion (114% increase, p < 0.0001) (Tab. 2), indicating that
the presence of AM suppresses MCP-1 production or that
enhanced neutrophil influx may be responsible for this
phenomenon of increased MCP-1 protein concentration.
As liposomes might interact with an ELISA technique and
thus lead to an incorrect result, BALF was also analyzed by
Western blot technique for TNF-α, MCP-1, and MIP-1β
concentrations (Fig. 2). TNF-α protein levels in BALF
decreased upon LPS stimulation in AM-depleted animals
compared to LPS-stimulated AM-competent animals
(60% decrease, p < 0.01, Fig. 2A). MCP-1 proteinRespiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
Page 5 of 14
(page number not for citation purposes)
concentration was enhanced in AM-depleted LPS animals
(126% increase, p < 0.01, Fig. 2B). Therefore, the results
were comparable with ELISA data. For MIP-1β, a decrease
of 53% was seen in AM-depleted LPS animals compared
to AM competent LPS animals (p < 0.01, Fig. 2C).
As it was unlikely that MCP-1 was the only PMN chemoat-
tractant further investigations were performed focusing
on MIP-2 and CINC-1. MIP-2 showed an increase of
230% in control liposome LPS animals compared to PBS
animals. 32% less protein were detected in clodronate LPS
animals than in control liposome LPS ones (p < 0.01)
(Fig. 2D). CINC-1 protein, however, showed a similar
increase as MCP-1 upon LPS stimulation in AM-depleted
animals compared to LPS animals with AM: it increased
from 10.9 ng/ml in control liposome LPS-animals to 19.7
ng/ml in clodronate LPS-animals, 86% increased, p <
0.01; Fig. 2E). Therefore, it could be considered as a che-
moattractant for PMN.
Cytokine, Chemokine, and Adhesion Molecule mRNA 
Expression in Rat Lung
To obtain more information on cytokine and chemokine
levels in the respiratory compartment of whole lungs,
mRNA was isolated from lungs 4 hours after airway instil-
lation of PBS or LPS in control liposome-and clodronate-
liposome animals (previously lavaged lungs). The pres-
ence of cytokines, chemokines and adhesion molecules
was assessed by reverse transcription-PCR (Fig. 3A–F). No
constitutive mRNA expression for TNF-α, IL-1β, MIP-1β,
MCP-1 was detectable in lung tissue of control liposome
animals, which received PBS. After instillation of LPS in
control liposome animals enhanced mRNA expression of
the analyzed cytokines and chemokines was demon-
strated. In LPS-stimulated AM-depleted animals, TNF-α
decreased by 32% (p < 0.01) in comparison to LPS-stim-
A: Total cell count in bronchoalveolar lavage fluid (BALF) Figure 1
A: Total cell count in bronchoalveolar lavage fluid (BALF). 
Animals were pretreated with control liposomes (co lip) or 
clodronate-liposomes (clodronate). 72 hours later 150 µg 
LPS was instilled intratracheally and lungs were evaluated 4 
hours later. Cells were analyzed using cytospin and Diff-
Quick staining. Values are mean ± SEM from 5 animals per 
group. B. Determination of myeloperoxidase (MPO) activity 
as a measure of parenchymal neutrophil content. Animals 
were pretreated with control liposomes (co lip) or clodro-
nate-liposomes (clodronate). 72 hours later 150 µg LPS was 
instilled intratracheally and lungs were evaluated 4 hours 
later. The right lung of each animal was removed and homog-
enized in sample buffer. Optical density was measured at 420 
nm over 360s. The value for control liposomes and PBS was 
defined as 1 and all other values were adapted. Values are 
mean ± SEM from 5 animals per group.
Table 2: Determination of TNF-α and MCP-1 in BALF by ELISA
TNF-α (ng/ml)
4 h 24 h
co lip + PBS 0.07 +/- 0.01 0.03 +/- 0.06
co lip + LPS 3.37 +/- 0.07 1.01 +/- 0.17
clodr. + PBS 0.04 +/ -0.00 0.07 +/- 0.11
clodr. + LPS 1.08 +/- 0.39* 1.12 +/- 0.13 n.s.
MCP-1 (ng/ml)
4 h 24 h
co lip + PBS 0.44 +/- 0.09 0.57 +/- 0.45
co lip + LPS 8.16 +/- 0.63 13.50 +/- 2.94
clodr. + PBS 5.00 +/- 0.31 2.07 +/- 1.05
clodr. + LPS 21.5 +/- 1.80** 11.13 +/- 2.76 n.s.
* p < 0.001, **p < 0.0001 clodr. LPS compared to co lip LPSRespiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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A. TNF-α and protein determination in bronchoalveolar lavage fluid of AM-competent (control liposome = co lip) and AM- depleted (clodronate) animals, exposed to PBS or LPS for 4 hours Figure 2
A. TNF-α and protein determination in bronchoalveolar lavage fluid of AM-competent (control liposome = co lip) and AM-
depleted (clodronate) animals, exposed to PBS or LPS for 4 hours. Proteins were electorphoresed on a SDS-polyacrylamide gel 
and transblotted to a nitrocellulose membrane. Densitometry was performed. One value for control liposomes and PBS was 
defined as 1 and all other values were adapted. Values are mean ± SEM from 5 animals (only 2 are shown). B. MCP-1 protein 
determination in bronchoalveolar lavage fluid of AM-competent and -depleted animals, exposed to PBS or LPS for 4 hours. 
Proteins were electorphoresed on a SDS-polyacrylamide gel and transblotted to a nitrocellulose membrane. Densitometry was 
performed. One value for control liposomes and PBS was defined as 1 and all other values were adapted. Values are mean ± 
SEM from 5 animals (only 2 are shown). C. MIP-1β protein determination in bronchoalveolar lavage fluid of AM-competent and 
-depleted animals, exposed to PBS or LPS for 4 hours. Proteins were electorphoresed on a SDS-polyacrylamide gel and trans-
blotted to a nitrocellulose membrane. Densitometry was performed. One value for control liposomes and PBS was defined as 
1 and all other values were adapted. Values are mean ± SEM from 5 animals (only 2 are shown). D. MIP-2 protein determina-
tion in bronchoalveolar lavage fluid of AM-competent and -depleted animals, exposed to PBS or LPS for 4 hours. Proteins were 
electorphoresed on a SDS-polyacrylamide gel and transblotted to a nitrocellulose membrane. Densitometry was performed. 
One value for control liposomes and PBS was defined as 1 and all other values were adapted. Values are mean ± SEM from 5 
animals (only 2 are shown). E. CINC concentration in bronchoalveolar lavage fluid (BALF) of AM-competent (control lipo-
somes = co lip) and AM-depleted (clodronate) animals, exposed to PBS or LPS for 4 hours. CINC was examined using a stand-
ard ELISA. Values are mean ± SEM from 5 animals.Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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ulated control liposome animals, while IL-1β was
decreased by 73% (p < 0.01). For the chemokines MIP-1β
and MCP-1, a reduction of 62%, respectively 14%, was
observed in mRNA expression in LPS-injured AM-
depleted animals compared to control liposome animals
stimulated with LPS (p < 0.0001, resp. p < 0.001). Only a
minor expression of ICAM-1-mRNA and VCAM-mRNA
was seen in control liposome PBS-animals. mRNA
increased in LPS-injured AM-competent and AM-depleted
animals compared to those animals receiving PBS. How-
ever the difference between AM-competent and AM-
depleted LPS-animals did not reach statistical
significance.
TNF-α-, MCP-1-, and MIP-1β Production in AEC and AM 
in Co-Culture
In vitro assays were performed to further explore the inter-
actions of AEC and AM in the respiratory compartment,
observed in vivo. In a first set of experiments, optimal con-
ditions were evaluated testing different seeding densities
and LPS concentrations (data not shown). AEC were co-
incubated with AM at a relation of 2:1 (AEC:AM) and
stimulated with 10 µg/ml LPS. Upon stimulation, TNF-α
production in AM increased from 0.98 ng/ml to 6.6 ng/ml
(p < 0.001), while AEC under control conditions pro-
duced 0.08 ng/ml and 1.6 ng/ml after LPS stimulation (p
< 0.001) (Fig. 4A). These in vitro results would support the
in vivo observations of decreased TNF-α concentrations in
BALF upon depletion of AM.
Unstimulated AEC showed a constitutive MCP-1 expres-
sion of 4.8 ng/ml, while MCP-1 concentration in the
supernatant decreased to 3.2 ng/ml, when co-incubating
AEC and AM (Fig. 4B). Upon LPS stimulation the follow-
ing observations were made: AEC produced 9.7 ng/ml (p
< 0.05), while in a system of AEC/AM co-incubation,
MCP-1 protein concentration was only 6.6 ng/ml. This
represents significantly less MCP-1 protein than produced
by AEC in mono-culture (p < 0.05). These findings cor-
roborate our in vivo data with less MCP-1 in the presence
of AM.
Analyzing the supernatants for MIP-1β concentration, it
was obvious that not only AM but also AEC produce MIP-
1β upon LPS stimulation (Fig. 4C). However, in contrast
to MCP-1 secretion, LPS-induced MIP-1β production was
increased by 153% when co-incubating AEC and AM.
Effect of Intratracheal Instillation of MCP-1 Antibody
Results of incrased PMN accumulation in the presence of
MCP-1 raised the question if MCP-1 has neutrophil che-
moattractant characteristics in this model. Therefore, an
MCP-1-blocking antibody was directly instilled into the
airways. Different amounts of antibody were tested (50
µg, 100 µg, and 150 µg). A maximal blocking effect on
Changes in expression of TNF-α mRNA (A), IL-1β mRNA  (B), MIP-1β mRNA (C), MCP-1 mRNA (D), ICAM-1 mRNA  (E) and VCAM-1 mRNA (F) of AM-competent (control lipo- somes = co lip) and -depleted (clodrondate) animals after 4  hours of PBS/LPS stimulation Figure 3
Changes in expression of TNF-α mRNA (A), IL-1β mRNA 
(B), MIP-1β mRNA (C), MCP-1 mRNA (D), ICAM-1 mRNA 
(E) and VCAM-1 mRNA (F) of AM-competent (control lipo-
somes = co lip) and -depleted (clodrondate) animals after 4 
hours of PBS/LPS stimulation. Whole lung RNA was 
extracted and RT-PCR performed according to the primers 
and annealing thermocycle conditions shown in Tab. 1. Equal 
loading was shown with 18S bands. Results were analyzed by 
densitometry. One value for control liposomes and PBS was 
defined as 1 and all other values were adapted. Values are 
mean ± SEM from 5 animals.Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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neutrophil accumulation was achieved with 100 µg.
Increasing the amount of MCP-1 antibody beyond this
dose did not result in a better blocking effect. Upon LPS
stimulation PMN recruitment into the respiratory com-
partment was attenuated by 50% (p < 0.001) (Fig. 5A) in
the presence of blocking antibodies, while interstitial
PMN content was decreased by 35% (p < 0.05) (Fig. 5B).
The same experiments were performed in control lip-
some-and clodronate-animals with LPS-induced lung
injury. Similar results were found with 57% (p < 0.005)
less neutrophils in the respiratory compartment (Fig. 5C)
and 50% (p < 0.001) less interstitial PMN (Fig. 5D).
Chemotactic Activity of BALF
To determine chemotactic activity in BALF of the different
animal groups, chemotaxis assays were performed. In
addition, the chemotactic activity of MCP-1 and CINC-1
was indirectly determined by using a neutralizing MCP-1
or CINC-1 antibody. Migration of PMN upon exposure to
BALF from PBS animals with or without AM was similar
(Fig. 6A and 6B). Upon LPS stimulation, it increased by
44% in the control liposome group (p < 0.05) and 76% in
the clodronate group (p < 0.01). Notably, blocking MCP-
1 in BALF with a neutralizing antibody decreased PMN
migration (18% in control liposome-LPS animals, p <
0.05, 30% in clodronate-LPS animals, p < 0.05) (Fig. 6A).
A 74% decrease of accumulation of neutrophils was
found in the clodronate-LPS group using a blocking
CINC-1 antibody (p < 0.05) (Fig. 6B).
Effect of Alveolar Macrophage Depletion after 24 Hours 
of LPS Stimulation
To further verify the role of AM at a later time point of
inflammation, LPS-injured lungs were analyzed after 24
hours. Interestingly, the impact of AM seemed to be differ-
ent at 24 hours than at 4 hours. As shown in Fig. 7A cell
recruitment was of similar magnitude in control lipo-
some-and clodronate-animals: 114.3 × 106 cells in control
liposome-LPS animals and 99.3 × 106 cells in BALF of
clodronate-LPS animals (n.s.). A similar result with no dif-
ference between control lipsome-and clodronate-LPS
group was seen in interstitial neutrophil recruitment (Fig.
7B). In addition to these findings, concentrations of TNF-
α and MCP-1 in the respiratory compartment were not
different in the two groups (Tab. 2). Furthermore there
was no difference in whole lung mRNA of TNF-α, IL-1β,
MIP-1β, MCP-1, ICAM-1, and VCAM-1 (data not shown).
Discussion
AM are considered to play a predominant role in the
inflammatory response to lung injury. An effective host
defense is primarily dependent on this cell type [18]. AM
do not only act as phagocytes, but have also a potent func-
tion as secretory cells. Upon stimulation, AM release a
A. TNF-α protein determination in supernatants of alveolar  epithelial cells (AEC), alveolar macrophages (AM) and co-cul- ture of AEC/AM upon LPS stimulation (relation AEC:AM =  2:1) Figure 4
A. TNF-α protein determination in supernatants of alveolar 
epithelial cells (AEC), alveolar macrophages (AM) and co-cul-
ture of AEC/AM upon LPS stimulation (relation AEC:AM = 
2:1). TNF-α was examined using a standard ELISA. White 
bars represent control cells, black bars LPS-stimulated cells. 
Values are mean ± SEM from 5 different assays. B. MCP-1 
protein determination in supernatants of alveolar epithelial 
cells (AEC), alveolar macrophages (AM) and co-culture of 
AEC/AM upon LPS stimulation (relation AEC:AM = 2:1). 
MCP-1 was examined using a standard ELISA. White bars 
represent control cells, black bars LPS-stimulated cells. Val-
ues are mean ± SEM from 5 different assays. C. MIP-1β pro-
tein determination in supernatants of alveolar epithelial cells 
(AEC), alveolar macrophages (AM) and co-culture of AEC/
AM upon LPS stimulation (relation AEC:AM = 2:1). MIP-1β 
was examined using Western blot analysis. Densitometry 
was performed. One value for control liposomes and PBS 
was defined as 1 and all other values were adapted. White 
bars represent control cells, black bars LPS-stimulated cells. 
Values are mean ± SEM from 5 different assays.Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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A. Total cell count in bronchoalveolar lavage fluid (BALF) Figure 5
A. Total cell count in bronchoalveolar lavage fluid (BALF). Rats were challenged with intratracheal instillation of LPS or PBS, 
followed by intratracheal application of MCP-1 antibody or a control antibody (IgG). Lungs were evaluated 4 hours later. Cells 
were analyzed using cytospin and Diff-Quick staining. Values are mean ± SEM from 5 animals. B. Determination of myeloperox-
idase (MPO) activity as a measure of parenchymal PMN content. Rats were challenged with intratracheal instillation of LPS or 
PBS, followed by intratracheal application of MCP-1 antibody or a control antibody (IgG). Lungs were evaluated 4 hours later. 
The right lung of each animal was removed and homogenized in sample buffer. Optical density was measured at 420 nm over 
360s. One value PBS+IgG was defined as 1 and all other values were adapted. Values are mean ± SEM from 5 animals. C. Total 
cell count in bronchoalveolar lavage fluid (BALF). AM-competent (control liposomes = co lip) and -depleted (clodrondate) ani-
mals were challenged with intratracheal instillation of LPS, followed by intratracheal application of MCP-1 antibody or a control 
antibody (IgG). Lungs were evaluated 4 hours later. Cells were analyzed using cytospin and Diff-Quick staining. Values are 
mean ± SEM from 5 animals. D. Determination of myeloperoxidase (MPO) activity as a measure of parenchymal PMN content. 
AM-competent (control liposomes = co lip) and -depleted (clodrondate) animals were challenged with intratracheal instillation 
of LPS, followed by intratracheal application of MCP-1 antibody or a control antibody (IgG). Lungs were evaluated 4 hours 
later. The right lung of each animal was removed and homogenized in sample buffer. Optical density was measured at 420 nm 
over 360s. One value LPS+IgG was defined as 1 and all other values were adapted. Values are mean ± SEM from 5 animals.Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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A. Chemotaxis assays performed with BALF of control lipo- some-PBS/LPS and clodronate-PBS/LPS animals Figure 6
A. Chemotaxis assays performed with BALF of control lipo-
some-PBS/LPS and clodronate-PBS/LPS animals. 1 × 105 poly-
morphonuclear cells (PMN) were labelled with calcein and 
given to the upper chamber, while the lower one was loaded 
with 150 µl of BALF. 10 µg/ml neutralizing anti-rat MCP-1 
antibody or 10 µg/ml control IgG were added to BALF. PBS/
1% fetal bovine serum was taken to determine basal migra-
tion. Migrated cells were lysed and fluorescence was meas-
ured by using an excitation filter at 485 nm and an emission 
filter at 535 nm. Ratio between stimulated and basal migra-
tion was used as indication of PMN chemotaxis. * p < 0.05 B. 
Chemotaxis assays performed with BALF of control lipo-
some-PBS/LPS and clodronate-PBS/LPS animals. 1 × 105 poly-
morphonuclear cells (PMN) were labelled with calcein and 
given to the upper chamber, while the lower one was loaded 
with 150 µl of BALF. 10 µg/ml neutralizing anti-rat CINC-1 
antibody or 10 µg/ml MOPC-21 were added to BALF. PBS/
1% fetal bovine serum was taken to determine basal migra-
tion. Migrated cells were lysed and fluorescence was meas-
ured by using an excitation filter at 485 nm and an emission 
filter at 535 nm. Ratio between stimulated and basal migra-
tion was used as indication of PMN chemotaxis. * p < 0.05
A: Total cell count in bronchoalveolar lavage fluid (BALF) Figure 7
A: Total cell count in bronchoalveolar lavage fluid (BALF). 
Animals were pretreated with control liposomes (co lip) or 
clodronate-liposomes (clodronate). 72 hours later 150 µg 
LPS was instilled intratracheally and lungs were evaluated 24 
hours later. Cells were analyzed using cytospin and Diff-
Quick staining. Values are mean ± SEM from 5 animals. B. 
Determination of myeloperoxidase (MPO) activity as a meas-
ure of parenchymal neutrophil content. Animals were pre-
treated with control liposomes (co lip) or clodronate-
liposomes (clodronate). 72 hours later 150 µg LPS was 
instilled intratracheally and lungs were evaluated 24 hours 
later. The right lung of each animal was removed and homog-
enized in sample buffer. Optical density was measured at 420 
nm over 360s. One value for control liposomes and PBS was 
defined as 1 and all other values were adapted. Values are 
mean ± SEM from 5 animals.Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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wide variety of biologically active molecules, which are
part of the complex regulatory system of inflammatory
reactions. A recent study demonstrated that depletion of
AM in a murine model of Klebsiella pneumoniae-induced
lung injury decreased survival dramatically by causing
100% lethality 3 days after infection, thereby demonstrat-
ing that AM exert a crucial role in this model [17]. In con-
trast to these findings, the elimination of AM promoted
pulmonary immunity in a model of Listeria-induced lung
injury [19]. To further examine the role of AM in the
pathogenesis of neutrophilic lung inflammation in the
early phase of LPS-induced lung injury, macrophages were
eliminated by administration of liposome-encapsulated
clodronate. Increased neutrophil recruitment was found
in depleted LPS-injured animals compared to non-
depleted LPS-injured animals. We postulated that beside
other neutrophil chemoattractants enhanced concentra-
tions of MCP-1 as detected in the respiratory compart-
ment might be responsible for this increase in neutrophil
recruitment. Therefore, AM could have an anti-inflamma-
tory effect at this early time point of injury suppressing
MCP-1 production by AEC.
Neutrophil accumulation in the lungs is one of the hall-
marks of an acute inflammatory response. The mecha-
nisms by which PMN are recruited into the lung in
response to inflammatory stimuli are unclear, but seem to
be dependent on the release of chemotactic and activating
cytokines and chemokines [20]. These molecules recruit
neutrophils and mediate their migration into the intersti-
tial and finally into the alveolar space. Several models of
lung injury have already been explored regarding
neutrophil recruitment after AM-depletion. A model of
AM-depletion with both intratracheally and intravenously
delivered liposome-encapsulated clodronate showed
decreased neutrophilic alveolitis in AM-depleted lungs
after exposure to aerosolic LPS [21]. In acute lung injury
induced by deposition of immunoglobulin G immune
complexes, myeloperoxidase activity was decreased by
60% in AMdepleted lungs compared to AM-competent
animals [16]. Similar results were seen in a model of Pseu-
domonas aeruginosa infection [22]. In a Klebsiella model of
lung injury, an increased number of neutrophils in AM-
depleted animals was observed after AM depletion [17].
This K. pneumoniae-induced PMN recruitment was shown
to be TNF-α-mediated. In our model with an increase of
PMN upon AM depletion, beside CINC-1, MCP-1 might
be a possible neutrophil chemoattractant in the respira-
tory compartment. Chemotaxis assays underlined this
hypothesis.
The role of MCP-1 regarding neutrophil accumulation in
inflammatory processes is controversial. The nature of the
injury is likely to determine the effect of MCP-1 on PMN.
MCP-1 has recently been shown to play a certain role in
PMN recruitment in various experimental systems [23-
25]. Johnston et al. demonstrated an induction of neu-
trophil chemotaxis in mesenteric tissue upon MCP-1
superfusion. MCP-1 could also be shown to be involved
in neutrophil accumulation during gastric ulceration.
Vozzelli et al. performed blocking studies with anti-MCP-
1 antibodies in newborn rats, exposed to hyperoxia [26].
Animals injected with 25 µg of anti-MCP-1 showed reduc-
tions in macrophage as well as neutrophil cell counts.
Decreasing macrophage and monocyte activation by treat-
ment with anti-MCP-1 might indirectly reduce neutrophil
influx by decreasing a significant cellular source of neu-
trophil chemokines. However, this group showed as well
an attenuation of PMN recruitment in hyperoxic rats,
treated with 5 µg anti-MCP-1 antibody, with an
unchanged number of alveolar macrophages, possibly
demonstrating the effect of MCP-1 on neutrophil
recruitment. Maus et al. postulated that JE/MCP-1
together with endotoxin, when co-appearing in the alveo-
lar compartment elict an early phase of lung
inflammatory injury with increased neutrophil recruit-
ment [27]. Treatment of mice with only JE/MCP-1
induced a monocyte, but not a neutrophil influx into the
bronchoalveolar compartment, with monocyte number
peaking at 48 hours. Challenging mice with endotoxin in
the presence of JE/MCP-1 led to an increase of neutrophils
at 12 hours, while monocyte counts peaked at 48 hours.
However, alveolar deposition of both MCP-1 and endo-
toxin was a prerequisite for the response as MCP-1 with-
out accompanying injury did not provoke neutrophil
emigration into the lung. Therefore, these studies do not
fully underline a chemoattractant component of MCP-1
regarding PMN recruitment. Another study of Maus et al.
reported decreased neutrophil and monocyte recruitment
in alveolar macrophage-depleted animals upon com-
bined JE/MCP-1/LPS treatment, also not supporting the
concept of MCP-1 as a neutrophil chemoattractant [28].
Notabely, the earliest time point after LPS application the
authors focused on was 6 hours, and never at 4 hours.
While our data demonstrated enhanced PMN accumula-
tion in LPS-injured AM-depleted animals, Koay et al.
showed decreased neutrophil recruitment upon LPS
stimulation in intratracheally and intravenously applied
clodronate mice at 4 hours of injury. However, there are
certain essential differences regarding the animal model.
1) Mice instead of rats were used. 2) An intratracheal and
intravenous depletion was performed in this study, while
we used only the intratracheal one. 3) Intratracheally
applied LPS was aerosolized, while we instilled LPS, dis-
solved in PBS. 4) Much higher doses of LPS were used in
mice than in rats, which could also explain a more severe
inflammation and therefore an immediate participation
of extraalveolar macrophages in the lung. Noteworthy is
the observation, that also in the study of Koay MCP-1Respiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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levels were increased in bronchoalveolar lavage fluid in
LPS-clodronate animals compared to LPS-control lipo-
some animals. Although the methodological approach by
Koay et al. and our experimental systems appear similar,
two clearly different models were used.
While in the presence of AM the amount of MCP-1 in
BALF was low in LPS-injured lungs, it increased dramati-
cally in the absence of AM, leading to the assumption that
epithelial cells are responsible for the majority of MCP-1
content in BALF, although a receptor-induced ligand
internalization can not be excluded. The production of
MCP-1 by epithelial cells has been demonstrated previ-
ously [29]. Our in vivo data lead to the new hypothesis,
that AEC in the presence of AM are modulated in their
activity in producing MCP-1. We therefore performed in
vitro assays with primary cultures of AEC and co-incuba-
tion of these cells with AM. After exposure to LPS, AEC/
AM together produced less MPC-1 protein than LPS-stim-
ulated AEC alone. This lead to the assumption that AM
potentially exert a negative control effect on AEC. A simi-
lar observation was made with human bronchial epithe-
lial cells (HBEC) and AM in culture, when exposed to
ambient pollution particles [30]. While most of the
inflammatory mediators such as TNF-α, IL-1β and IL-6
were significantly increased upon stimulation of the
HBEC/AM-co-culture, MCP-1 production was decreased.
This in vitro phenomenon could help to understand the
increased levels of MCP-1 protein in the BALF of AM-
depleted animals, although limitations of in vitro models
are well known and results have to be interpreted with
caution.
Contrary to MCP-1, TNF-α protein in BALF of AM-
depleted LPS-animals was decreased significantly as well
as whole lung mRNA of TNF-α. A study with hyperoxia in
AM-depleted rats showed no significant differences in
lung TNF-α content [31]. In contrast to the observation in
our experiments in AM-depleted LPS-lungs, an increase of
TNF-α in the AM-depleted Klebsiella pneumonia lungs was
observed 2 days after the onset of the injury [17]. Several
factors could explain these differing observations: 1. The
difference of TNF-α content might reflect the difference in
time points at which the lung injury was assessed. While
TNF-α was evaluated at an early time point in the LPS-
model, the analysis was performed in the Klebsiella model
after 2 days. Kinetic expression of TNF-α is known to be
time-variable [32]. 2. The mechanism of the inflamma-
tory response to bacteria or toxins might bear different
characteristics. 3. Alveolar macrophages have been shown
to secrete large amounts of TNF-α, while interstitial mac-
rophages are more efficient in releasing IL-1β and IL-6
[33]. This finding supports our observation with a mark-
edly reduced content of TNF-α protein in BALF and
moderate decrease of whole lung mRNA for TNF-α. In our
in vitro data, AM are the dominant cells secreting TNF-α.
In the pulmonary tissue compartment – in contrast to the
airway compartment – elimination of macrophages
resulted in decreased production of mRNA for TNF-α, IL-
1β, and MIP-1β in LPS-injured lungs, but only to a degree
between 10 and 60%. These data suggest that other cells
than AM contribute to tissue injury. The discrepant obser-
vation of minimal MCP-1 mRNA and protein decrease in
whole lung and on the other side a MCP-1 increase in the
BAL was observed in other models of lung injury [21]. The
most likely explanation for this discrepancy is that the
inflammatory reactions do not bear the same characteris-
tics in different compartments of the lung. mRNA of the
adhesion molecules ICAM-1 and VCAM-1 was not
changed. Therefore, it can be concluded that AM do not
affect the expression of these important inflammatory
mediators. This is in accordance with previous data show-
ing that whole lung ICAM-1 is regulated by about 80%
through TNF-α [1]. In our studies, mRNA for TNF-α was
only decreased by 32%, which might not be sufficient to
elicit an ensuing change in ICAM-1 mRNA.
In order to define the role of AM at a later time point dur-
ing LPS-induced lung injury, AM depletion was performed
and lungs were collected 24 hours after LPS instillation.
No difference in neutrophil recruitment between lungs
with or without AM was observed. Two conclusions could
be drawn from these experiments: 1) AM do not play the
same critical functional role any more regarding PMN
recruitment at this later time point of injury. As previously
shown by Xing et al. AM play a key role in the very early
LPS-induced lung inflammation [34]. 2) New AM were
recruited during 24 hours of injury. Depletion of AM has
been observed to persist for 5 days, followed by an
increase of AM (unpublished data). These data were eval-
uated without application of any injury. In the present
model, however, recruitment of new macrophages in
response to the injury can be assumed.
The current study provides evidence for an important pro-
tective role of AM very early in the course of LPS-induced
lung injury. AM were shown to affect neutrophil recruit-
ment by reducing the accumulation of PMNs, most likely
via suppression of alveolar epithelial MCP-1 production.
This observation was surprising and not in accordance
with our previously stated hypothesis. The precise role
and the mechanisms of AM in the up-or downregulation
of inflammatory mediators remain to be further investi-
gated. Therapeutic options for the effective management
of endotoxin-induced lung injury are still very limited.
Therefore, the detailed exploration of an animal model of
LPS-induced lung injury with regard to the role ofRespiratory Research 2005, 6:61 http://respiratory-research.com/content/6/1/61
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macrophages will be helpful for the determination of the
mechanistic and activation pathways.
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